Clinigen Drug Patent Portfolio
Clinigen owns 1 orange book drug protected by 1 US patent Given below is the list of Clinigen's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6727253 | Treatment of accidental extravasation of anthracyclines | 13 Mar, 2020 | Expired |
Latest Legal Activities on Clinigen's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Clinigen.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Petition Decision - Dismissed
Critical
| 05 Oct, 2016 | US6727253 |
|
Mail-Petition Decision - Dismissed
Critical
| 05 Oct, 2016 | US6727253 |
| Petition Entered | 04 Apr, 2016 | US6727253 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Sep, 2013 | US6727253 |
|
Correspondence Address Change
Critical
| 16 Sep, 2013 | US6727253 |
|
Recordation of Patent Grant Mailed
Critical
| 27 Apr, 2004 | US6727253 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 27 Apr, 2004 | US6727253 |
|
Issue Notification Mailed
Critical
| 08 Apr, 2004 | US6727253 |
| Receipt into Pubs | 18 Mar, 2004 | US6727253 |
|
Application Is Considered Ready for Issue
Critical
| 17 Mar, 2004 | US6727253 |
|
Issue Fee Payment Verified
Critical
| 05 Feb, 2004 | US6727253 |
|
Issue Fee Payment Received
Critical
| 05 Feb, 2004 | US6727253 |
| Receipt into Pubs | 12 Dec, 2003 | US6727253 |
| Dispatch to Publications | 09 Dec, 2003 | US6727253 |
|
Mail Notice of Allowance
Critical
| 05 Nov, 2003 | US6727253 |
Clinigen's Family Patents
Clinigen Drug List
Given below is the complete list of Clinigen's drugs and the patents protecting them.
1. Totect
Totect is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6727253 | Treatment of accidental extravasation of anthracyclines |
13 Mar, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Totect's drug page